HIMS stock news · Hims & Hers Health Inc.
Get alerts for HIMS
Follow Hims & Hers Health Inc. (HIMS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for HIMSHims & Hers is fighting a lawsuit by saying it was clear about its subscription rules and privacy policies.
NeutralHims & Hers is asking a court to dismiss a lawsuit over privacy, subscription charges, and cancellations. The case remains unresolved, so the story does not change its outlook.
Big investors are making moves in 10 health care stocks today.
NeutralThe alert marked Hims & Hers Health's call trade bearish. It reports trading activity, not a company change, so it does not change the company's outlook.
Hims & Hers Health, Inc. has new leaders after some directors left and Jonathan M. Franklin was named chief accounting officer.
NeutralHims & Hers appointed a new chief accounting officer, and the former officer will help through July 2027. The handoff and added pay do not change the company's business outlook.
Today, big trades were spotted in 4 health care stocks.
NeutralHIMS had a call option trade labeled bearish. One trade does not show a change in the company's business, and the article reports no new results.
Today, there are big trades happening in 10 health care stocks.
NeutralThe article lists a Hims & Hers call sweep tagged bearish. One options trade, without news about the company's business, does not change its outlook.
Big investors are making moves in 10 health care stocks today.
Bad for HIMSHims & Hers had a call option trade labeled bearish; 406 contracts were traded at the $50 strike expiring Jan 21, 2028.
FDA Issues Alert on Misleading GLP-1 Weight Loss Medications.
Bad for HIMSThe FDA issued a warning about the health risks associated with unapproved GLP-1 weight-loss medications, leading to a decline in Hims & Hers Health's stock and raising concerns for Eli Lilly and Novo Nordisk due to their involvement with the active ingredients in these medications.
What Factors Led to BONER Meme Coin Becoming a Major Narrative on Robinhood?
NeutralThe BONER meme coin locked up a significant portion of the tokenized float of Hims & Hers Health on Robinhood Chain, causing a temporary spike in the price of the tokenized shares, which was later corrected when the NYSE opened.
Hims & Hers defends against privacy claims while vowing to enhance patient accessibility.
Good for HIMSHims & Hers is currently facing a lawsuit from the FTC regarding privacy allegations, which has raised concerns among investors. However, the CEO's defense and the company's commitment to expanding patient access may provide a counterbalance to the negative sentiment, leading to mixed market reactions.
According to an optimistic analyst, Hims & Hers Health requires investments to achieve sustainable incremental growth.
NeutralHims & Hers Health reported strong quarterly results, exceeding revenue and EBITDA estimates, and raised its full-year guidance, which is expected to positively influence investor sentiment. The partnership with Novo Nordisk is also highlighted as a key driver for growth.
Hims & Hers Health shares decline on Tuesday amid mixed Q2 performance.
NeutralHims & Hers Health's stock fell after the company reported mixed second-quarter results, with a larger-than-expected loss overshadowing strong revenue growth and subscriber increases. The market reacted negatively to concerns over shrinking profit margins and rising costs associated with new product lines.
Hims & Hers Health Inc. experiences share price decline following a mixed Q2 earnings report.
NeutralHims & Hers Health Inc. reported a mixed Q2 earnings report, missing EPS estimates while beating revenue expectations. This has led to a decline in share price, reflecting investor concerns despite positive revenue growth and subscriber increases.
Q2 loss anticipated for Hims & Hers Health as top analysts adjust predictions prior to earnings announcement.
Bad for HIMSHims & Hers Health is anticipated to report a significant quarterly loss, which could lead to a bearish sentiment among investors. The earnings report is crucial as it follows a period of growth, and the expected decline in earnings may affect stock performance.